Thrivent Financial for Lutherans Has $6.22 Million Stock Holdings in Itron, Inc. (NASDAQ:ITRI)

Thrivent Financial for Lutherans lowered its stake in shares of Itron, Inc. (NASDAQ:ITRI) by 3.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 62,877 shares of the scientific and technical instruments company’s stock after selling 2,443 shares during the period. Thrivent Financial for Lutherans’ holdings in Itron were worth $6,222,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in ITRI. Los Angeles Capital Management LLC bought a new stake in Itron in the 1st quarter valued at about $2,002,000. Commonwealth Equity Services LLC bought a new stake in shares of Itron during the first quarter valued at approximately $1,076,000. Jupiter Asset Management Ltd. acquired a new position in shares of Itron during the first quarter worth approximately $2,029,000. Oppenheimer & Co. Inc. lifted its holdings in shares of Itron by 91.1% in the 4th quarter. Oppenheimer & Co. Inc. now owns 30,568 shares of the scientific and technical instruments company’s stock worth $2,308,000 after purchasing an additional 14,573 shares in the last quarter. Finally, UniSuper Management Pty Ltd acquired a new stake in Itron in the 1st quarter valued at $904,000. Institutional investors own 96.19% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on ITRI. TD Cowen upped their price objective on shares of Itron from $115.00 to $125.00 and gave the stock a “buy” rating in a report on Friday, August 2nd. Guggenheim raised shares of Itron from a “neutral” rating to a “buy” rating and set a $130.00 price target on the stock in a research report on Thursday, July 11th. StockNews.com lowered Itron from a “strong-buy” rating to a “buy” rating in a report on Friday, June 28th. Oppenheimer lifted their target price on Itron from $110.00 to $112.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Finally, BNP Paribas assumed coverage on Itron in a research report on Thursday, September 5th. They issued an “outperform” rating and a $133.00 price target for the company. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, Itron presently has an average rating of “Moderate Buy” and a consensus price target of $118.64.

Itron Stock Down 0.0 %

ITRI opened at $103.05 on Friday. Itron, Inc. has a twelve month low of $56.11 and a twelve month high of $113.07. The company’s 50-day moving average price is $100.89 and its two-hundred day moving average price is $99.73. The stock has a market cap of $4.73 billion, a price-to-earnings ratio of 29.61, a PEG ratio of 0.90 and a beta of 1.47. The company has a quick ratio of 2.61, a current ratio of 3.16 and a debt-to-equity ratio of 0.98.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Thursday, August 1st. The scientific and technical instruments company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.25. The business had revenue of $609.07 million during the quarter, compared to analyst estimates of $599.25 million. Itron had a return on equity of 16.42% and a net margin of 7.98%. Itron’s revenue was up 12.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.65 earnings per share. As a group, equities analysts expect that Itron, Inc. will post 4.59 earnings per share for the current year.

Insider Buying and Selling

In other Itron news, CFO Joan S. Hooper sold 509 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $102.15, for a total transaction of $51,994.35. Following the sale, the chief financial officer now directly owns 72,338 shares of the company’s stock, valued at $7,389,326.70. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CEO Thomas Deitrich sold 887 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $102.15, for a total transaction of $90,607.05. Following the completion of the transaction, the chief executive officer now directly owns 205,276 shares in the company, valued at $20,968,943.40. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Joan S. Hooper sold 509 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $102.15, for a total value of $51,994.35. Following the completion of the transaction, the chief financial officer now owns 72,338 shares of the company’s stock, valued at $7,389,326.70. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,776 shares of company stock valued at $584,721. 1.45% of the stock is owned by insiders.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.